Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.5 - $1.79 $11,900 - $42,602
23,800 Added 476.0%
28,800 $21,000
Q3 2023

Nov 14, 2023

SELL
$1.44 - $4.76 $16,128 - $53,312
-11,200 Reduced 69.14%
5,000 $8,000
Q2 2023

Aug 14, 2023

BUY
$3.95 - $10.4 $21,725 - $57,200
5,500 Added 51.4%
16,200 $65,000
Q1 2023

May 15, 2023

SELL
$7.84 - $12.57 $610,736 - $979,203
-77,900 Reduced 87.92%
10,700 $105,000
Q4 2022

Feb 14, 2023

BUY
$5.86 - $13.74 $452,392 - $1.06 Million
77,200 Added 677.19%
88,600 $706,000
Q3 2022

Nov 14, 2022

SELL
$11.57 - $17.36 $56,693 - $85,064
-4,900 Reduced 30.06%
11,400 $146,000

Others Institutions Holding NSTG

About NanoString Technologies Inc


  • Ticker NSTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,494,100
  • Description
  • NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCoun...
More about NSTG
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.